awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38261371-0BAE4F03-45FD-4E29-8C8D-8FAE048B31C5
Q38261371-0BAE4F03-45FD-4E29-8C8D-8FAE048B31C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38261371-0BAE4F03-45FD-4E29-8C8D-8FAE048B31C5
Selective JAK inhibitors.
P2860
Q38261371-0BAE4F03-45FD-4E29-8C8D-8FAE048B31C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38261371-0BAE4F03-45FD-4E29-8C8D-8FAE048B31C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
42b479344aa27b1478bcd154323dc72d33c05930
P2860
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse